Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More Analysis and Commentary STEVEN GROSSMAN 1/8/21 Analysis and Commentary STEVEN GROSSMAN 1/8/21 Now We Know Who'll Be in Charge Read More Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More Analysis and Commentary STEVEN GROSSMAN 11/2/18 Analysis and Commentary STEVEN GROSSMAN 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More Advocacy at a Glance STEVEN GROSSMAN 11/2/18 Advocacy at a Glance STEVEN GROSSMAN 11/2/18 Will Congress Complete Appropriations in the Post-Recess Session? Read More Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Changes and Growth at the FDA Read More Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Analysis and Commentary STEVEN GROSSMAN 1/19/17 Analysis and Commentary STEVEN GROSSMAN 1/19/17 Will Next Monday Be Different Than Today? Read More Analysis and Commentary STEVEN GROSSMAN 11/21/16 Analysis and Commentary STEVEN GROSSMAN 11/21/16 Significant Change Is Always Hard Read More Analysis and Commentary STEVEN GROSSMAN 10/21/16 Analysis and Commentary STEVEN GROSSMAN 10/21/16 Plus ça Change, Plus c'est la Même Chose (or Maybe Not) Read More Analysis and Commentary STEVEN GROSSMAN 7/15/16 Analysis and Commentary STEVEN GROSSMAN 7/15/16 Coming Soon: A Future Year of Massive Change Read More Analysis and Commentary STEVEN GROSSMAN 11/7/14 Analysis and Commentary STEVEN GROSSMAN 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More
Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More
Analysis and Commentary STEVEN GROSSMAN 1/8/21 Analysis and Commentary STEVEN GROSSMAN 1/8/21 Now We Know Who'll Be in Charge Read More
Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More
Analysis and Commentary STEVEN GROSSMAN 11/2/18 Analysis and Commentary STEVEN GROSSMAN 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More
Advocacy at a Glance STEVEN GROSSMAN 11/2/18 Advocacy at a Glance STEVEN GROSSMAN 11/2/18 Will Congress Complete Appropriations in the Post-Recess Session? Read More
Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Changes and Growth at the FDA Read More
Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Analysis and Commentary STEVEN GROSSMAN 1/19/17 Analysis and Commentary STEVEN GROSSMAN 1/19/17 Will Next Monday Be Different Than Today? Read More
Analysis and Commentary STEVEN GROSSMAN 11/21/16 Analysis and Commentary STEVEN GROSSMAN 11/21/16 Significant Change Is Always Hard Read More
Analysis and Commentary STEVEN GROSSMAN 10/21/16 Analysis and Commentary STEVEN GROSSMAN 10/21/16 Plus ça Change, Plus c'est la Même Chose (or Maybe Not) Read More
Analysis and Commentary STEVEN GROSSMAN 7/15/16 Analysis and Commentary STEVEN GROSSMAN 7/15/16 Coming Soon: A Future Year of Massive Change Read More
Analysis and Commentary STEVEN GROSSMAN 11/7/14 Analysis and Commentary STEVEN GROSSMAN 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More
